TIDMAVCT

RNS Number : 8242T

Avacta Group PLC

23 July 2015

 
 23 July 2015

Avacta Group plc

("Avacta", the "Company" or the "Group")

Issue of Equity

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for life sciences, today announces that 250,000 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options by an employee.

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 28 July 2015.

The total number of Ordinary Shares in issue following the above issue will be 4,979,649,550 each with voting rights. No Ordinary Shares are held in Treasury.

The above figure of 4,979,649,550 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

- Ends -

For further information:

 
 Avacta Group plc                                  Tel: +44 (0) 844 414 
  Alastair Smith, Chief Executive Officer           0452 
  Tim Sykes, Chief Financial Officer                www.avacta.com 
 
   Numis Securities Limited                          Tel: +44 (0) 207 260 
   Michael Meade / Freddie Barnfield - Nominated     1000 
   Adviser                                           www.numiscorp.com 
   James Black - Corporate Broking 
 
   Media Enquiries                                   Tel: +44 (0) 20 3727 
   FTI Consulting                                    1000 
   Simon Conway / Natalie Garland-Collins            avacta@fticonsulting.com

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through two divisions:

 
 
   Avacta Animal Health           Veterinary diagnostics reference laboratory 
   www.avactaanimalhealth.com     and diagnostic kit provider. 
 
   Avacta Life Sciences           Novel non-antibody affinity reagents 
   www.avactalifesciences.com     called Affimers, with a wide range of 
                                  Life Science applications in diagnostics, 
                                  drug and biomarker discover and biotech 
                                  research and development. 
                               ----------------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEUUONRVUABUAR

Avacta (LSE:AVCT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Avacta Charts.
Avacta (LSE:AVCT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Avacta Charts.